Endothelium-targeted heptapeptides displayed at AAV9 capsid amino-acid residue A589 modulate the transduction efficiency of AAV9 vectors on human endothelial cells So far, we could show that our ...
- Collaboration focuses on gene therapies for serious eye diseases and leverages Dyno’s CapsidMap™ artificial intelligence platform to design AAV vectors - - Financial terms include upfront ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback